Leman's new heart valve beats rival products
This article was originally published in Clinica
Executive Summary
Animal studies have shown that Leman Cardiovascular's third-generation heart valve performs better than rival products. The way is now clear for human trials, due "in early 2008", said CEO Benedict Broennimann.